Literature DB >> 35657482

Surgical Management of Melanoma: Advances and Updates.

Juan A Santamaria-Barria1, Joshua M V Mammen2.   

Abstract

PURPOSE OF REVIEW: To review and update surgeons about the evolving complexities in the surgical management of melanoma including lymph node staging and treatment. RECENT
FINDINGS: Primary resection with adequate margins continues to be the standard of care for localized cutaneous melanoma. Sentinel lymph node biopsy is confirmed to be a powerful tool due to its prognostic value and informative guidance for adjuvant treatments and surveillance. Due to the lack of benefit in melanoma-specific survival and distant metastasis-free survival, completion lymph node dissection is not performed routinely after a positive sentinel lymph node biopsy. Neoadjuvant systemic treatment approaches for advanced loco-regional disease show promise in phase I and II clinical trial data, and phase III studies. The surgical management of cutaneous melanoma continues to evolve with further de-escalation of the extent of excision of primary melanomas and the management of lymph node disease.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Immunotherapy; Lymphadenectomy; Margins; Melanoma; Neoadjuvant immunotherapy; Surgical oncology

Year:  2022        PMID: 35657482     DOI: 10.1007/s11912-022-01289-x

Source DB:  PubMed          Journal:  Curr Oncol Rep        ISSN: 1523-3790            Impact factor:   5.075


  48 in total

1.  Five-Year Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma.

Authors:  James Larkin; Vanna Chiarion-Sileni; Rene Gonzalez; Jean-Jacques Grob; Piotr Rutkowski; Christopher D Lao; C Lance Cowey; Dirk Schadendorf; John Wagstaff; Reinhard Dummer; Pier F Ferrucci; Michael Smylie; David Hogg; Andrew Hill; Ivan Márquez-Rodas; John Haanen; Massimo Guidoboni; Michele Maio; Patrick Schöffski; Matteo S Carlino; Céleste Lebbé; Grant McArthur; Paolo A Ascierto; Gregory A Daniels; Georgina V Long; Lars Bastholt; Jasmine I Rizzo; Agnes Balogh; Andriy Moshyk; F Stephen Hodi; Jedd D Wolchok
Journal:  N Engl J Med       Date:  2019-09-28       Impact factor: 91.245

2.  Surgical margins in cutaneous melanoma (2 cm versus 5 cm for lesions measuring less than 2.1-mm thick).

Authors:  David Khayat; Olivier Rixe; Ginette Martin; Claude Soubrane; Martine Banzet; Jacques-André Bazex; Philippe Lauret; Olivier Vérola; Gérard Auclerc; Peter Harper; Pierre Banzet
Journal:  Cancer       Date:  2003-04-15       Impact factor: 6.860

3.  Long-Term Outcomes and Responses to Retreatment in Patients With Melanoma Treated With PD-1 Blockade.

Authors:  Allison Betof Warner; Jessica S Palmer; Alexander N Shoushtari; Debra A Goldman; Katherine S Panageas; Sara A Hayes; Raazi Bajwa; Parisa Momtaz; Margaret K Callahan; Jedd D Wolchok; Michael A Postow; Paul B Chapman
Journal:  J Clin Oncol       Date:  2020-02-13       Impact factor: 44.544

4.  Narrow excision (1-cm margin). A safe procedure for thin cutaneous melanoma.

Authors:  U Veronesi; N Cascinelli
Journal:  Arch Surg       Date:  1991-04

5.  2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: a randomised, multicentre trial.

Authors:  Peter Gillgren; Krzysztof T Drzewiecki; Marianne Niin; Hans P Gullestad; Henrik Hellborg; Eva Månsson-Brahme; Christian Ingvar; Ulrik Ringborg
Journal:  Lancet       Date:  2011-10-23       Impact factor: 79.321

Review 6.  Optimal excision margins for primary cutaneous melanoma: a systematic review and meta-analysis.

Authors:  Philip I Haigh; L Andrew DiFronzo; David R McCready
Journal:  Can J Surg       Date:  2003-12       Impact factor: 2.089

7.  Resection margins of 2 versus 5 cm for cutaneous malignant melanoma with a tumor thickness of 0.8 to 2.0 mm: randomized study by the Swedish Melanoma Study Group.

Authors:  U Ringborg; R Andersson; J Eldh; B Glaumann; L Hafström; S Jacobsson; P E Jönsson; H Johansson; L Krysander; B Lagerlöf
Journal:  Cancer       Date:  1996-05-01       Impact factor: 6.860

8.  Excision margins in high-risk malignant melanoma.

Authors:  J Meirion Thomas; Julia Newton-Bishop; Roger A'Hern; Gill Coombes; Michael Timmons; Judy Evans; Martin Cook; Jeffery Theaker; Mary Fallowfield; Trevor O'Neill; Wlodek Ruka; Judith M Bliss
Journal:  N Engl J Med       Date:  2004-02-19       Impact factor: 91.245

9.  Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial.

Authors:  C M Balch; M M Urist; C P Karakousis; T J Smith; W J Temple; K Drzewiecki; W R Jewell; A A Bartolucci; M C Mihm; R Barnhill
Journal:  Ann Surg       Date:  1993-09       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.